Principia Biopharma Inc (PRNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -53,792 | 18,167 | -28,697 | -30,638 |
| Depreciation Amortization | 269 | -135 | 5,673 | 3,690 |
| Accounts payable and accrued liabilities | -2,082 | 1,034 | 1,280 | 696 |
| Other Working Capital | -880 | -43,328 | 52,236 | 593 |
| Other Operating Activity | 13,939 | 3,089 | -3,644 | 815 |
| Operating Cash Flow | $-42,546 | $-21,173 | $26,848 | $-24,844 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -180,452 | -145,799 | N/A | N/A |
| PPE Investments | -2,171 | -1,067 | -90 | -12 |
| Investing Cash Flow | $-182,623 | $-146,866 | $-90 | $-12 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 0 | 0 | 8,060 | 13,433 |
| Common Stock Issued | 230,135 | 112,141 | 317 | 10 |
| Other Financing Activity | 0 | 49,800 | 0 | 0 |
| Financing Cash Flow | $230,135 | $161,941 | $8,377 | $13,443 |
| Exchange Rate Effect | N/A | N/A | 52 | -9 |
| Beginning Cash Position | 35,138 | 41,236 | 6,049 | 17,471 |
| End Cash Position | 40,104 | 35,138 | 41,236 | 6,049 |
| Net Cash Flow | $4,966 | $-6,098 | $35,187 | $-11,422 |
| Free Cash Flow | ||||
| Operating Cash Flow | -42,546 | -21,173 | 26,848 | -24,844 |
| Capital Expenditure | -2,171 | -1,067 | -90 | -12 |
| Free Cash Flow | -44,717 | -22,240 | 26,758 | -24,856 |